BC2L-C 莱克的糖相对抗剂:从分子动力学模拟的见解
Giulia Antonini1, Monica Civera1, Kanhaya Lal1,2
1Università degli Studi di Milano, Dipartimento di Chimica, Milano, Italy.
Frontiers in molecular biosciences
|June 16, 2023
概括
研究人员开发了一种计算方法来研究新的抗感染药物如何与Burkholderia cenocepacia BC2L-C lectin结合. 这种方法有助于设计更好的药物来对抗危险的医院感染.
科学领域:
- 生物化学 生物化学
- 计算生物学 计算生物学
- 微生物学 微生物学
背景情况:
- 像Burkholderia cenocepacia这样的多药耐药病原体对医院患者构成重大风险,特别是那些免疫力低下或患有囊性纤维化的人.
- B. cenocepacia 的 BC2L-C 莱克对细菌粘附和生物膜形成至关重要,使其成为抗菌战略的潜在目标.
研究的目的:
- 建立和验证一个计算工作流程,用于研究新型双功能甘氨基仿真配体和BC2L-C莱克N终端域 (BC2L-C-Nt) 之间的相互作用.
- 探索结合联体的分子基础和这些甘氨基/乳素复合物的动态行为.
- 评估计算方法是否适用于指导新抗感染剂的设计.
主要方法:
- 开发一个计算工作流程,涉及分子对接连体到BC2L-C-Nt剪切器.
- 使用MM-GBSA重新得分对接姿势的改进.
- 在明确的水中进行分子动力学 (MD) 模拟,以研究连接物-莱克相互作用.
- 计算结果与X射线晶体学和异热定位热量计的实验数据进行比较.
主要成果:
- 计算工作流程成功地描述了糖相对应体和BC2L-C-Nt.Nt之间的相互作用.
- 在明确溶剂中的MD模拟对于与实验观测的良好相关性至关重要.
- 这项研究提供了关于连接体结合和复杂动态的基础分子机制的见解.
结论:
- 经过验证的计算协议是有效的,用于研究糖相对应物 - 莱克相互作用.
- 这种工作流可以指导基于结构的增强BC2L-C-Nt连接体的设计.
- 这些改进的配体有望成为新型抗微生物药物,具有对B. cenocepacia感染的抗粘性.
相关概念视频
01:31Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
01:14Glycocalyx and its Functions
4.2K
The glycocalyx is a carbohydrate-rich, fuzzy-appearing layer on the outer surface of the cell membrane. It is highly hydrophilic, because of this it attracts large amounts of water to the cell's surface. This aids the cell's interaction with the watery environment and also helps it to obtain substances dissolved in the water. It is also important for cell identification, self/non-self determination, and embryonic development and is used in cell-to-cell attachments to form tissues.
4.2K
01:24Glucagon-like Receptor Agonists
369
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
369
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
218
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
218